Process evaluation and exploration of telehealth in motor neuron disease in a UK specialist centre

BMJ Open. 2019 Oct 22;9(10):e028526. doi: 10.1136/bmjopen-2018-028526.

Abstract

Objectives: To evaluate the processes involved in using a novel digitally enabled healthcare system (telehealth in motor neuron disease (TiM)) in people living with motor neuron disease (MND) and their informal carers. We examined TiM implementation, potential mechanisms of impact and contextual factors that might influence TiM implementation or impact.

Design: An 18-month, single-centre process evaluation within a randomised, pilot and feasibility study.

Intervention: TiM plus usual care versus usual care alone.

Setting: A specialist UK MND care centre.

Participants: 40 patients with MND and 37 primary informal carers.

Primary and secondary outcome measures: Patient, carer and staff outcomes and experiences using semistructured interviews. Descriptive data on implementation and use of TiM.

Results: The TiM was acceptable and accessible to patients, carers and staff. Intervention uptake and adherence were good: 14 (70%) patients completed a TiM session at least fortnightly. Barriers to TiM use (such as technology experience and disability) were overcome with well-designed technology and face-to-face training. Reported potential benefits of TiM included improved communication and care coordination, reassurance, identification of complications and the potential for TiM to be an alternative or addition to clinic. Benefits depended on patients' current level of needs or disability. The main challenges were the large number of alerts that were generated by TiM, how the clinicians responded to these alerts and the mismatch between patient/carer expectations and nurses actions. This could be improved by better communication systems and adjusting the alerts algorithm.

Conclusion: TiM has the potential to facilitate access to specialist care, but further iterative developments to the intervention and process evaluations of the TiM in different services are required.

Trial identifier number: ISRCTN26675465.

Keywords: amyotrophic lateral sclerosis; motor neuron disease; process evaluation; qualitative; telehealth; telemedicine.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Communication
  • Feasibility Studies
  • Female
  • Health Services Accessibility
  • Humans
  • Male
  • Middle Aged
  • Motor Neuron Disease / therapy*
  • Pilot Projects
  • Process Assessment, Health Care*
  • Telemedicine*
  • United Kingdom

Associated data

  • ISRCTN/ISRCTN26675465